Osaic Holdings’s Abivax ABVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$44.5K Buy
450
+280
+165% +$33.8K ﹤0.01% 5602
2026
Q2
$22.7K Buy
170
+85
+100% +$9.6K ﹤0.01% 6086
2026
Q1
$9.46K Sell
85
-20
-19% -$2.37K ﹤0.01% 6470
2025
Q4
$14.2K Buy
105
+68
+184% +$7.42K ﹤0.01% 6105
2025
Q3
$3.08K Buy
+37
New +$2.27K ﹤0.01% 6988
2025
Q1
– Sell
-25
Closed -$183 – 7422
2024
Q4
$183 Sell
25
-7
-22% -$64 ﹤0.01% 7177
2024
Q3
$369 Buy
32
+26
+433% +$312 ﹤0.01% 7066
2024
Q2
$79 Buy
+6
New +$86 ﹤0.01% 7269

Other funds holding ABVX

Osaic Holdings's ABVX Position: Q3 2026 in Review

Osaic Holdings increased its Abivax (ABVX) stake by 165% in Q3 2026, buying an estimated $33.8K and bringing the position to 450 shares worth $44.5K. The position accounts for ﹤0.01% of the portfolio, ranked #5602.

Osaic Holdings first reported a position in ABVX in Q2 2024 and has held it in 8 quarters since. 319 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.

  • Osaic Holdings held 450 shares of Abivax worth $44.5K as of Q3 2026.
  • Osaic Holdings bought 280 Abivax shares in Q3 2026, an estimated $33.8K.
  • Abivax made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #5602 holding.
  • Osaic Holdings first reported a position in Abivax in Q2 2024 and has held it in 8 quarters since.
  • 319 funds tracked by Wall St. Rank held Abivax as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.